Only Large Reductions in Concentrations of Natriuretic Peptides (BNP and NT-proBNP) Are Associated with Improved Outcome in Ambulatory Patients with Chronic Heart Failure
Author:
Affiliation:
1. Cardiovascular Division, Mayo Medical Center, Rochester, MN
2. Department of Biostatistics, Mayo Medical Center, Rochester, MN
3. Department of Laboratory Medicine and Pathology, Mayo Medical Center, Rochester, MN
Abstract
Funder
Siemens
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry
Link
http://academic.oup.com/clinchem/article-pdf/55/1/78/32872731/clinchem0078.pdf
Reference24 articles.
1. Prognostic Impact of Plasma N-Terminal Pro–Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure
2. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
3. Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure
4. N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients
5. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. sST2 and Big ET-1 as Alternatives of Multi-Biomarkers Strategies for Prognosis Evaluation in Patients Hospitalized with Heart Failure;International Journal of General Medicine;2023-11
2. Sex-Specific Thresholds for Cardiac Biomarkers—We Need to Move Forward;Reviews in Cardiovascular Medicine;2023-03-08
3. Factors associated with hospitalisations of patients with chronic heart failure approaching the end of life: A systematic review;Palliative Medicine;2022-09-28
4. Serial, Repeated, or Single Measurements of Natriuretic Peptides (BNP or NT‐proBNP) in Estimating Cardiovascular Risk: Is It the “Importance of Change Over Time” or “The Past Is Good, But the Present Is Better,” or Both, in Clinical Context?;Journal of the American Heart Association;2022-04-19
5. Biomarkers in Acute Heart Failure Syndromes: An Update;Current Cardiology Reviews;2021-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3